GenAns Biotech
Latest round
- Series A
Last raised
- Jul 2026
Total raised
- Undisclosed
Investors
- 10
About GenAns Biotech
, trading as GenAns Biotech, focusing on developing advanced gene delivery systems for therapeutic applications. GenAns Biotech specializes in innovative gene therapies focused on central nervous system (CNS) disorders and ophthalmic diseases. The company implements advanced neurobiological knowledge and high-throughput screening technologies to develop gene delivery systems targeting specific cells and tissues for therapeutic applications. Their primary offerings include an AAV high-throughput directional evolution screening platform, a functional protein screening platform, and a drug development platform, all aimed at addressing the unmet clinical needs associated with hereditary and neurological diseases. GenAns Biotech's revenue generation model is primarily based on partnerships and collaborations with healthcare institutions and research organizations.
Who invested in GenAns Biotech
10 investors across 4 rounds
See all investors in GenAns Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GenAns Biotech
Who invested in GenAns Biotech?
GenAns Biotech has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GenAns Biotech raised?
GenAns Biotech has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did GenAns Biotech last raise money?
GenAns Biotech's most recent round on record is a Series A, in Jul 2026.
What does GenAns Biotech do?
, trading as GenAns Biotech, focusing on developing advanced gene delivery systems for therapeutic applications.
Where is GenAns Biotech headquartered?
GenAns Biotech is headquartered in Beijing, China.
Which VCs invest in companies like GenAns Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at GenAns Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like GenAns Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.